Drug Emporium
This article was originally published in The Rose Sheet
Executive Summary
Health and beauty drugstore chain and e-tailer will be delisted from the NASDAQ Stock Market Jan. 26 if minimum common stock price does not rise above $1 for 10 consecutive days, the company announces Nov. 22. Company has failed to maintain a minimum bid price of $1 over the past 30 days
You may also be interested in...
Drug Emporium
Drug and personal care retailer delisted from Nasdaq on close of trade March 14 following consecutive stock declines, firm announces. Beginning March 15, company's common stock listed on OTC Bulleting Board. Drug Emporium was warned in November that it would be delisted if its stock price did not rise above $1 for 10 consecutive days (1"The Rose Sheet" Nov. 27, 2000, In Brief)
OCA Applauds Organic Board's Recommendation To USDA: "Outlaw Nanotech"
With a push from the Organic Consumers Association, the National Organic Standards Board is recommending that the use of nanotechnology be strictly prohibited from products certified under the National Organic Program